Rosecliff Acquisition I today filed an investor presentation highlighting its proposed merger with Spectral MD Holdings, an AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care.
As announced in April, terms call for Spectral MD to receive in excess of $20 million (assuming no redemptions). This includes approximately $4.5 million held in Rosecliff’s trust (again, assuming no redemptions) and an expected private placement investment of at least $15 million.
The deal is not subject to any minimum cash condition for closing.
Reed Smith is serving as a legal advisor to Spectral MD. S.P. Angel Corporate Finance is nominated adviser and broker in connection with the transaction.
Skadden, Arps, Slate, Meagher & Flom is legal advisor to Rosecliff. Read more.
